Abbott Laboratories (ABT) Revenue — Quarter Ended Dec 31, 2024
The company reported revenue growth in the fourth quarter. Both sequential and year-over-year comparisons were positive.
Key takeaway
Quarter ended Dec 31, 2024 · FY2024 Q4
The company reported revenue growth in the fourth quarter. Both sequential and year-over-year comparisons were positive.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$11B
Revenue reported for this quarter.
Quarter-over-quarter
+3.2%
Change from the immediately preceding quarter.
Year-over-year
+7.2%
Change from the comparable year-ago quarter.
Trailing four quarters
$42B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Mar 31, 2024 | $10B | +2.2% |
| Jun 30, 2024 | $10.4B | +4.0% |
| Sep 30, 2024 | $10.6B | +4.9% |
| Dec 31, 2024 | $11B | +7.2% |
Revenue performance
Revenue increased compared to the prior quarter, driven by continued business momentum. The year-over-year growth was even stronger.
Quarterly comparison
Sequentially, revenue rose, while on an annual basis the increase was more pronounced.
What to watch
The sequential growth rate moderated compared to the prior quarter.